CMAR_A_243329 2531..2540
暂无分享,去创建一个
K. Hua | J. Qiu | Xiaoyan Tang | Chenyan Guo | Yan Ding | Jingjing Guo | Songping Liu | J. Qiu
[1] R. Reiter,et al. Melatonin: A new inhibitor agent for cervical cancer treatment , 2019, Journal of cellular physiology.
[2] Michael R Hamblin,et al. Pathogenic role of exosomes and microRNAs in HPV‐mediated inflammation and cervical cancer: A review , 2019, International journal of cancer.
[3] A. Avan,et al. Curcumin inhibits NF-kB and Wnt/β-catenin pathways in cervical cancer cells. , 2019, Pathology, research and practice.
[4] Hamed Mirzaei,et al. microRNAs: New prognostic, diagnostic, and therapeutic biomarkers in cervical cancer , 2019, Journal of cellular physiology.
[5] Xuehao Wang,et al. Circular RNA MAT2B Promotes Glycolysis and Malignancy of Hepatocellular Carcinoma Through the miR‐338‐3p/PKM2 Axis Under Hypoxic Stress , 2019, Hepatology.
[6] Y. Ghasemi,et al. Circular RNAs in cancer: new insights into functions and implications in ovarian cancer , 2019, Journal of Ovarian Research.
[7] Shasha Li,et al. Microarray is an efficient tool for circRNA profiling , 2019, Briefings Bioinform..
[8] Z. Zeng,et al. circMAN1A2 could serve as a novel serum biomarker for malignant tumors , 2019, Cancer science.
[9] P. McMurrick,et al. The role of preoperative CEA in the management of colorectal cancer: A cohort study from two cancer centres. , 2019, International journal of surgery.
[10] E. Vasile,et al. Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer , 2019, British Journal of Cancer.
[11] Zhonghao Liu,et al. Forkhead box O3 promotes colon cancer proliferation and drug resistance by activating MDR1 expression , 2019, Molecular genetics & genomic medicine.
[12] A. Hoffman,et al. A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1 , 2018, Genome Biology.
[13] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[14] Hui Yuan,et al. Circular RNA as a biomarker for cancer: A systematic meta-analysis. , 2018, Oncology letters.
[15] Wenchen Pu,et al. Circular RNA F-circEA produced from EML4-ALK fusion gene as a novel liquid biopsy biomarker for non-small cell lung cancer , 2018, Cell Research.
[16] Hui Zhao,et al. Identification of the tumor-suppressive function of circular RNA FOXO3 in non-small cell lung cancer through sponging miR-155 , 2018, Molecular medicine reports.
[17] J. Soh,et al. Restrictive ventilatory impairment is associated with poor outcome in patients with cT1aN0M0 peripheral squamous cell carcinoma of the lung. , 2017, Journal of thoracic disease.
[18] G. Scambia,et al. The relevance of prelamin A and RAD51 as molecular biomarkers in cervical cancer , 2017, Oncotarget.
[19] Yu-Jin Dong,et al. Circular RNA expression profiles reveal that hsa_circ_0018289 is up-regulated in cervical cancer and promotes the tumorigenesis , 2017, Oncotarget.
[20] Ji-Feng Feng,et al. Combination of c-reactive protein and squamous cell carcinoma antigen in predicting postoperative prognosis for patients with squamous cell carcinoma of the esophagus , 2017, Oncotarget.
[21] Ji-Feng Feng,et al. Combination of c-reactive protein and squamous cell carcinoma antigen in predicting postoperative prognosis for patients with squamous cell carcinoma of the esophagus , 2017, Oncotarget.
[22] Laising Yen,et al. Noncoding Effects of Circular RNA CCDC66 Promote Colon Cancer Growth and Metastasis. , 2017, Cancer research.
[23] Faryal Mehwish Awan,et al. Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity , 2016, Cell Death and Differentiation.
[24] Weining Yang,et al. Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2 , 2016, Nucleic acids research.
[25] S. Dasari,et al. Cervical cancer: Biomarkers for diagnosis and treatment. , 2015, Clinica chimica acta; international journal of clinical chemistry.
[26] Li Zhang,et al. Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] G. Packham,et al. FOXO3 expression during colorectal cancer progression: biomarker potential reflects a tumour suppressor role , 2013, British Journal of Cancer.
[28] H. Young,et al. Humoral autoimmune responses to the squamous cell carcinoma antigen protein family in psoriasis. , 2008, The Journal of investigative dermatology.
[29] D. Tindall,et al. Dynamic FoxO transcription factors , 2007, Journal of Cell Science.
[30] C. Sternberg,et al. Are nomograms better than currently available stage groupings for bladder cancer? , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] G. Silverman,et al. Uteroglobin Suppresses SCCA Gene Expression Associated with Allergic Asthma* , 2005, Journal of Biological Chemistry.
[32] S. Naylor,et al. Promise and Challenge: Markers of Prostate Cancer Detection, Diagnosis and Prognosis , 2004, Disease markers.
[33] R. O’Brien,et al. Regulation of Phosphoenolpyruvate Carboxykinase and Insulin-like Growth Factor-binding Protein-1 Gene Expression by Insulin , 2000, The Journal of Biological Chemistry.
[34] Lijuan Zhang,et al. Serum SCCA levels in patients suffering cancers or other diseases. , 2019, Progress in molecular biology and translational science.
[35] A. Bufalino,et al. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta‐analysis , 2018, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[36] Junming Guo,et al. Plasma circular RNA profiling of patients with gastric cancer and their droplet digital RT-PCR detection , 2017, Journal of Molecular Medicine.
[37] J. Manola,et al. Cancer Management and Research Dovepress , 2022 .